Skip to main content

Muñoz Vaño, Vicent

Institutions of which they are part

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Muñoz Vaño, Vicent

Institutions of which they are part

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Vall Hebron Institut de Recerca

Projects

ROL DE LA APELINA EN LA ENFERMEDAD RENAL DIABÉTICA: DEL RATÓN AL HUMANO

IP: Maria Jose Soler Romeo
Collaborators: Marina Lopez Martinez, Jordi Vilardell Vilà, Irene Martinez Diaz, Sheila Bermejo Garcia, Vicent Muñoz Vaño, Carmen Llorens Cebriá, M Antonieta Azancot Rivero, Enzamaría Fidilio Meli, Juan Carlos León Román, Sara Nuñez Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI24/01510
Duration: 01/01/2025 - 31/12/2027

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

Related professionals

Daniel Sevilla Sánchez

Daniel Sevilla Sánchez

Senior researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Ana Maria  De Andres  Lázaro

Ana Maria De Andres Lázaro

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Borja González Rodríguez

Borja González Rodríguez

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Marta de Dios Lascuevas

Marta de Dios Lascuevas

Predoctoral researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.